Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force.

Autor: Tervonen T; Kielo Research, Zug, Switzerland. Electronic address: tommi.tervonen@kieloresearch.com., Veldwijk J; Erasmus School of Health Policy and Management & Erasmus Choice Modelling Center, Rotterdam, The Netherlands., Payne K; Manchester Centre for Health Economics, School of Health Sciences, The University of Manchester, Manchester, England, UK., Ng X; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Levitan B; Global R&D Epidemiology, Janssen R&D, Titusville, NJ, USA., Lackey LG; Decision Support and Analysis Staff, Office of Program and Strategic Analysis, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Marsh K; Evidera, London, England, UK., Thokala P; School of Health and Related Research, University of Sheffield, Sheffield, England, UK., Pignatti F; European Medicines Agency, Amsterdam, The Netherlands., Donnelly A; Patient Council of the Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA., Ho M; Google, San Francisco, CA, USA.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2023 Apr; Vol. 26 (4), pp. 449-460.

Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMIS.

Autor: Lackey LG; Decision Support and Analysis Staff, Office of Program and Strategic Analysis, Office of Special Programs, Center for Drug Evaluation and Research (L.G.L.), Food and Drug Administration, Silver Spring, MD., Garnett CE; Division of Cardiology and Nephrology, Office of Cardiology, Hematology, Endocrinology and Nephrology, Office of New Drugs, Center for Drug Evaluation and Research (C.E.G., F.S.), Food and Drug Administration, Silver Spring, MD., Senatore F; Division of Cardiology and Nephrology, Office of Cardiology, Hematology, Endocrinology and Nephrology, Office of New Drugs, Center for Drug Evaluation and Research (C.E.G., F.S.), Food and Drug Administration, Silver Spring, MD.

Publikováno v: Circulation [Circulation] 2021 Aug 24; Vol. 144 (8), pp. 655-658. Date of Electronic Publication: 2021 Aug 23.

Prevalence of potentially neuropathic Campylobacter jejuni strains on commercial broiler chicken products.

Autor: Hardy CG; Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA., Lackey LG, Cannon J, Price LB, Silbergeld EK

Publikováno v: International journal of food microbiology [Int J Food Microbiol] 2011 Feb 28; Vol. 145 (2-3), pp. 395-9. Date of Electronic Publication: 2011 Jan 08.